Covalon Technologies Ltd
XTSX:COV
Covalon Technologies Ltd
XTSX:COV
Price:
1.8
CAD
-1.64%
Market Cap:
CA$49.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Covalon Technologies Ltd
XTSX:COV
|
CA |
|
W
|
Wangli Security & Surveillance Product Co Ltd
SSE:605268
|
CN |
|
Volkswagen AG
XETRA:VOW3
|
DE |
|
Goldpac Group Ltd
HKEX:3315
|
HK |
|
S
|
Sarawak Plantation Bhd
KLSE:SWKPLNT
|
MY |
|
B
|
Beeio Honey Ltd
TASE:BHNY
|
IL |
|
X
|
XIIlab Co Ltd
KOSDAQ:189330
|
KR |
|
G
|
Globavend Holdings Ltd
NASDAQ:GVH
|
AU |
Multiples-Based Value
The
Multiples-Based Value for
Covalon Technologies Ltd (COV)
under the Base Case is
hidden
CAD.
Compared with the current market price of 1.8 CAD, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
COV Multiples-Based Value
LOCKED
Multiples Across Competitors
COV Competitors Multiples
Covalon Technologies Ltd Competitors
Covalon Technologies Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Covalon Technologies Ltd
XTSX:COV
|
49.7m CAD | 1.6 | 50.9 | 23.1 | 66.6 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
365.4B USD | 5.8 | 85.4 | 14.2 | 19.8 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
184.6B USD | 4.9 | 23.6 | 13.8 | 13.8 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.9B USD | 5.8 | 20.2 | 12.6 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.3B USD | 9 | 27.4 | 20.5 | 21.4 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.7B USD | 5.5 | 17.6 | 13 | 14.9 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67B AUD | 3 | 33.2 | 11.2 | 14 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.6B EUR | 11.3 | 36.2 | 39.4 | 40.2 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
